ASN Member Alert

ASN Member Alert



February 20, 2008


TO:
ASN Members
FROM:
ASN Policy Board
RE:
CMS Report to Congress on a Fully Bundled Medicare Payment System for ESRD


Yesterday afternoon the Centers for Medicare and Medicaid Services (CMS) released a long-awaited report on End Stage Renal Disease (ESRD) bundling for dialysis services.   The report to Congress includes analysis that CMS states “lays a solid foundation to implement a more accurate payment system, which would benefit patients.”  The report is required by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and outlines the steps to be taken by Congress to implement a fully-bundled prospective payment system for dialysis services.  

A major concern to ASN is that CMS has raised the possibility of including physicians' evaluation and management services encompassed in the monthly capitated payment (MCP) into an expanded bundle. This could potentially threaten the autonomy and independence of the nephrologist, as physician compensation for dialysis services could be determined by the dialysis provider.

CMS has proposed two ESRD bundled payment options.  The following is a brief summary of the CMS proposal(s).

 Broad bundle:

A broad bundle would include: composite rate services, ESRD-related separately billed injectable drugs, laboratory tests used in furnishing dialysis services that are not currently included in the composite rate, other dialysis related services,  MCP physicians’ services, outpatient vascular access maintenance, and ESRD-related outpatient hospital services.

Modified Bundle:

A modified bundle would include: composite rate services, ESRD-related separately billed injectable drugs, laboratory tests used in furnishing dialysis services that are not currently included in the composite rate, and other dialysis related services (e.g., syringes).  Certain oral medications that substitute for injectable drugs commonly used in ESRD patients (e.g., iron and vitamin D preparations) could also be included in the bundle.   

The ASN Policy Board, ASN Practicing Nephrologists Advisory Group and the ASN Dialysis Advisory Group will closely monitor this issue and will forward any new information to our members as quickly as possible.  In addition to developing our own advocacy plan, ASN is in contact with our sister societies - NKF, ASPN, and RPA - to discuss joint advocacy efforts on this issue.    

For your information, we have provided a link to the CMS Report to Congress and the CMS Press Release.